• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病的一级预防:是否可行?是否有效?

Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?

机构信息

Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.

出版信息

Hematology Am Soc Hematol Educ Program. 2011;2011:434-9. doi: 10.1182/asheducation-2011.1.434.

DOI:10.1182/asheducation-2011.1.434
PMID:22160070
Abstract

Consideration of primary prophylaxis to prevent complications of sickle cell disease (SCD) requires a clear understanding of the earliest manifestations of SCD-related organ injury, a reliable clinical or laboratory tool to detect organ dysfunction, and evidence that an intervention instituted in the presymptomatic state can mitigate disease progression. This review examines the pathophysiology of SCD in organs that may be potential targets for intervention, our current capacity to evaluate early SCD manifestations, results of clinical trials, and opportunities for future interventions.

摘要

考虑到预防镰状细胞病(SCD)并发症的一级预防,需要清楚了解 SCD 相关器官损伤的最早表现,需要有可靠的临床或实验室工具来检测器官功能障碍,并且有证据表明在出现症状前的状态下进行干预可以减轻疾病进展。本文综述了可能成为干预目标的 SCD 器官的病理生理学、我们目前评估早期 SCD 表现的能力、临床试验结果以及未来干预的机会。

相似文献

1
Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?镰状细胞病的一级预防:是否可行?是否有效?
Hematology Am Soc Hematol Educ Program. 2011;2011:434-9. doi: 10.1182/asheducation-2011.1.434.
2
Sickle cell disease--pathophysiology, clinical and diagnostic implications.镰状细胞病——病理生理学、临床及诊断意义
Clin Chem Lab Med. 2002 Nov;40(11):1075-84. doi: 10.1515/CCLM.2002.189.
3
The Challenges and Opportunities Associated with Sickle Cell Disease Prevention, Education, and Management.
Soc Work Public Health. 2015;30(7):592-612. doi: 10.1080/19371918.2015.1087905. Epub 2015 Oct 12.
4
Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.巴西镰状细胞病患者的严重程度:严重程度评分及贝叶斯网络模型使用的可行性
Blood Cells Mol Dis. 2015 Apr;54(4):321-7. doi: 10.1016/j.bcmd.2015.01.011. Epub 2015 Feb 23.
5
Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.镰状细胞病中的氧化应激;病理生理学及其对疾病管理的潜在影响。
Am J Hematol. 2011 Jun;86(6):484-9. doi: 10.1002/ajh.22012. Epub 2011 May 4.
6
Sickle cell nephropathy - a practical approach.镰状细胞肾病 - 一种实用的方法。
Br J Haematol. 2011 Nov;155(3):287-97. doi: 10.1111/j.1365-2141.2011.08853.x. Epub 2011 Sep 9.
7
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理:专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
8
Sickle cell disease: current activities, public health implications, and future directions.镰状细胞病:当前活动、公共卫生影响及未来方向。
J Womens Health (Larchmt). 2007 Jun;16(5):575-82. doi: 10.1089/jwh.2007.CDC4.
9
Definitions of the phenotypic manifestations of sickle cell disease.镰状细胞病表型表现的定义。
Am J Hematol. 2010 Jan;85(1):6-13. doi: 10.1002/ajh.21550.
10
Growth and nutritional status of children with homozygous sickle cell disease.纯合子镰状细胞病患儿的生长发育及营养状况
Ann Trop Paediatr. 2008 Sep;28(3):165-89. doi: 10.1179/146532808X335624.

引用本文的文献

1
Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC.镰状细胞病患儿的肾小球滤过率发生改变:Hb SS与Hb SC的比较。
Rev Bras Hematol Hemoter. 2013;35(5):349-51. doi: 10.5581/1516-8484.20130107.